학술논문
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
Document Type
Article
Author
Casabonne, D.; Benavente, Y.; Chirlaque, M.-D.; Sánchez, M.-J.; Amiano, P.; Barricarte, A.; de Sanjosé, S.; Costas, L.; Seifert, J.; Armesto, M.; Arestin, M.; Lawrie, C.H.; Besson, C.; Perduca, V.; Mancini, F.R.; Hosnijeh, F.S.; Vermeulen, R.; Duell, E.J.; Weiderpass, E.; Masala, G.; Kaaks, R.; Canzian, F.; Pala, V.; Trichopoulou, A.; Karakatsani, A.; La Vecchia, C.; Tumino, R.; Gunter, M.J.; Panico, S.; Sacerdote, C.; Schmidt, J.A.; Boeing, H.; Schulze, M.B.; Riboli, E.; Olsen, A.; Tjønneland, A.; Nieters, A.
Source
In: International Journal of Cancer . (International Journal of Cancer, 1 September 2020, 147(5):1315-1324)
Subject
Language
English
ISSN
10970215
00207136
00207136